DSC Advisors, L.P. - KEMPHARM INC ownership

KEMPHARM INC's ticker is and the CUSIP is 488445AB3. A total of 3 filers reported holding KEMPHARM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
DSC Advisors, L.P. ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2019$3,473,000
-10.1%
8,250,0000.0%0.69%
+1.2%
Q2 2019$3,865,000
-6.1%
8,250,0000.0%0.68%
-10.2%
Q1 2019$4,115,000
+0.3%
8,250,0000.0%0.76%
+52.1%
Q4 2018$4,104,000
-17.5%
8,250,0000.0%0.50%
-25.5%
Q3 2018$4,975,000
-10.8%
8,250,0000.0%0.67%
-26.5%
Q2 2018$5,577,000
-8.8%
8,250,0000.0%0.91%
-29.1%
Q1 2018$6,112,000
+14.0%
8,250,0000.0%1.28%
-58.9%
Q4 2017$5,363,0000.0%8,250,0000.0%3.11%
+82.0%
Q3 2017$5,363,000
-2.2%
8,250,0000.0%1.71%
-5.4%
Q2 2017$5,486,0008,250,0001.81%
Other shareholders
KEMPHARM INC shareholders Q1 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 75,000,000$57,250,0001.98%
DSC Advisors, L.P. 8,250,000$6,112,0001.28%
KINGDON CAPITAL MANAGEMENT, L.L.C. 3,000,000$2,065,0000.16%
View complete list of KEMPHARM INC shareholders